TATA Health International Holdings Limited (stock code: 01255) submitted its monthly return to Hong Kong Exchanges and Clearing Limited on 3 September 2026, covering the period ended 31 August 2026.

The filing shows that authorised share capital remained unchanged at 500.00 million ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 5.00 million.

Issued share capital was steady at 242.85 million ordinary shares, while the company continued to hold zero treasury shares. No new shares were issued, repurchased, or cancelled during the month.

TATA Health confirmed compliance with the Main Board’s Initial Prescribed Threshold, maintaining at least a 25% public float as required under Rule 13.32D(1).

The report indicates no outstanding share options, warrants, convertible instruments, or other equity-linked agreements.

The disclosure was authorised by Director Zhang Ming Qi.